Thiotepa 100 mg Powder for Solution for Infusion, 1 Vial
Thiotepa 100 mg Powder for Solution for Infusion, 1 Vial — Antineoplastics & Supportive Oncology Medicines, as a powder for infusion, available for private-label manufacture from 10,000 units, produced in Turkey. Below, the active substance of this Antineoplastics & Supportive Oncology Medicines product appears under its International Nonproprietary Name, with the strength per unit that the specification gives.
Offered for the Gulf states
This page lists formulations we offer for the Gulf states only. The Products Library shows every formulation open in your market.
| Dosage form | Powder for infusion |
|---|---|
| Pack | 1 vial per box |
| Minimum order | 10,000 units |
| Manufactured in | Turkey |
| Market | Offered for the Gulf states |
| Documents | Certificate of Analysis, Certificate of Origin, Certificate of Conformity, Free Sale Certificate and MSDS — available on request. |
| Products Library | Open this formulation's card (F2159) |
Active ingredients
- Thiotepa 100 mg per vial
Powder for solution for infusion containing thiotepa 100 mg per vial, an alkylating agent. Prescription medicine for intravenous infusion after reconstitution in hospital under specialist supervision; one vial per box.
This product is on offer for the Gulf states. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Country pages: Saudi Arabia · UAE · Kuwait · Qatar · Oman · Bahrain
Shipping and document legalisation for your country are calculated separately and stated in the offer.